Seeking Alpha
 

Amarantus Bioscience Holdings, Inc. (AMBS)

- OTCPK - Current
From other sites
Visit Seeking Alpha's
AMBS vs. ETF Alternatives
Company Description
Amarantus BioScience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. AMBS has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready small molecule indicated for Parkinson's... More